Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04969783 · ClinicalTrials.gov registry record · NA

Telehealth-Filter Ventilation ( COMET2P1 )

A NA study, sponsored by Masonic Cancer Center, University of Minnesota.

Completed
Registry status
NA
Development phase
164
Enrollment target

NCT04969783: Completed NA study, sponsored by Masonic Cancer Center, University of Minnesota.

NCT04969783 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04969783, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.

COMPLETED
Registry status
NA
Development phase
164 participants
Enrollment target

Study Summary

The goals of this project are to determine the effects of varying degrees of cigarette filter ventilation on biomarkers of toxicant exposure and smoking behavior and on subjective responses to the cigarette. The primary aim of this study is to examine the effects of unventilated vs ventilated filter cigarettes on urinary biomarkers of toxicant exposure and smoking behavior (e.g., cigarettes per day, intensity of smoking). The secondary objectives are 1) to examine the effects of cigarette filter ventilation on subjective measures such as cigarette dependence and responses to study cigarettes.

Primary Outcome

Absolute change from baseline level of total NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) at the week 6 visit (ng/g creatinine) measured in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Interventions

  • OTHER Ventilated Cigarette Filter
  • OTHER Unventilated Cigarette Filter

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2021-05-26
Est. Completion 2024-03-21
Phase NA

What the finished NCT04969783 record still lists

NCT04969783 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which Ventilated Cigarette Filter is the first listed.

NCT04969783 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04969783 about?

NCT04969783 is a clinical study titled "Telehealth-Filter Ventilation ( COMET2P1 )". The goals of this project are to determine the effects of varying degrees of cigarette filter ventilation on biomarkers of toxicant exposure and smoking behavior and on subjective responses to the cigarette. The primary aim of this study is to examine the effects of unventilated vs ventilated filte...

What is the current status of trial NCT04969783?

This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2021-05-26. Estimated completion is 2024-03-21.

What interventions are being tested in trial NCT04969783?

The interventions under investigation include: Ventilated Cigarette Filter (OTHER), Unventilated Cigarette Filter (OTHER).

Who is sponsoring clinical trial NCT04969783?

This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04969783's enrollment target sits among peer trials

164 626th of 2000 higher than 1,374 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04891289 · 164 participants · Phase 2

    Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

  • NCT04893226 · 164 participants · NA

    Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

  • NCT05270213 · 164 participants · Phase 1

    Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

  • NCT05543681 · 164 participants · Phase 2

    Clinical Trial on Agitation in Alzheimer's Dementia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04969783, the US trial registry maintained by the National Library of Medicine. NCT04969783 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.